ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1364

Incidence of Rheumatoid Arthritis in a Cohort of First Degree Relatives from the Studies of the Etiology of Rheumatoid Arthritis

Diraj R. Karnani1, Lindsy J. Forbess2, Michael Weisman3, Kevin D. Deane4, V. Michael Holers5 and Jill M. Norris6, 1Department of Rheumatology, Cedars Sinai Medical Center, Los Angeles, CA, 2Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 3Cedars-Sinai Medical Center Division of Rheumatology, Los Angeles, CA, 4Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 5Rheumatology Division, University of Colorado School of Medicine, Aurora, CO, 6Department of Epidemiology, Colorado School of Public Health, Aurora, CO

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: family studies, observation and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: First-degree relatives (FDRs) of patients with rheumatoid arthritis (RA) are at increased risk for developing RA compared to the general population. The purpose of the study reported herein was to evaluate the incidence rate of RA from a local cohort of FDRs that was initiated in 2004.

Methods: FDRs of patients with RA from Cedars-Sinai Medical Center (CSMC) enrolled in the Studies of the Etiology of RA (SERA, a multicenter prospective cohort of FDRs of probands with RA) were studied (Kolfenbach 2009). Participants were enrolled between 2004 and 2011, providing an average of 9.5 years of follow-up. FDRs who live in Southern California within approximately 150 miles of CSMC were contacted by phone and asked if they were given a diagnosis of RA by a rheumatologist or if they reported pain in one or more joints, and/or swelling or morning stiffness. If they had symptoms, but were not yet diagnosed with RA, they were evaluated in clinic by a rheumatologist and underwent testing for CCP antibodies (CCP 3.1).

Results: 250 FDRs enrolled in SERA between 2004 and 2011 and seen at CSMC who live in Southern California were contacted by telephone. 73 out of 250 subjects (29.2%) were reached to date. 2/73 FDRs (3%) reported a diagnosis of RA by a rheumatologist. Both FDRs diagnosed with RA were seronegative at the time of enrollment in the SERA cohort. One who was initially seronegative in 2007 seroconverted in 2011, with CCP2 and RF IgG positivity – she was diagnosed with RA in 2014. The second FDR diagnosed with RA remained seronegative for the duration of follow-up, even post-diagnosis. 9 of 73 FDRs (12.3%) had arthralgias defined as pain in one or more joints. Of these, 4 of the 9 have been evaluated to date by a rheumatologist in clinic without evidence of RA; none were CCP positive.

Conclusion: Our local cohort follow-up suggests that FDRs of patients with RA develop RA at a higher rate than the general population with an incidence rate of 3% in FDRs versus 0.4% in the general population over 10 years1. This is an ongoing effort to prospectively evaluate the risk of development of RA from a subgroup of FDRs established in the United States (SERA).

References:

1. Myasoedova, Elena, et al. “Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955–2007.” Arthritis & Rheumatology 62.6 (2010): 1576-1582.


Disclosure: D. R. Karnani, None; L. J. Forbess, None; M. Weisman, None; K. D. Deane, Inova Diagnostics, Inc., 5; V. M. Holers, None; J. M. Norris, None.

To cite this abstract in AMA style:

Karnani DR, Forbess LJ, Weisman M, Deane KD, Holers VM, Norris JM. Incidence of Rheumatoid Arthritis in a Cohort of First Degree Relatives from the Studies of the Etiology of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/incidence-of-rheumatoid-arthritis-in-a-cohort-of-first-degree-relatives-from-the-studies-of-the-etiology-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-of-rheumatoid-arthritis-in-a-cohort-of-first-degree-relatives-from-the-studies-of-the-etiology-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology